U.S. Markets closed

Prestige Consumer Healthcare Inc. (PBH)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
54.01+0.75 (+1.41%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close53.26
Bid50.48 x 800
Ask59.50 x 800
Day's Range52.73 - 54.13
52 Week Range49.15 - 63.83
Avg. Volume279,303
Market Cap2.706B
Beta (5Y Monthly)0.65
PE Ratio (TTM)15.25
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateSep 27, 2018
1y Target EstN/A
  • GlobeNewswire

    Prestige Consumer Healthcare Inc. Reports Record Results for Fiscal 2022

    Company Exceeds Full-Year Earnings Outlook for Revenue, EPS, and Cash FlowRevenue of $266.9 Million in Q4 and $1,086.8 Million for Full-Year Fiscal 2022, up 12.3% and 15.2% versus Prior Year, respectivelyAdjusted Diluted EPS of $4.06 for Fiscal 2022, up 25.3% versus Prior YearNet Cash Provided by Operating Activities of $259.9 Million and Record Non-GAAP Free Cash Flow of $253.7 Million in Full-Year Fiscal 2022Initial Full-Year Fiscal 2023 Revenue Outlook of Approximately 3% to 4%Board of Direct

  • GlobeNewswire

    Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Fourth Quarter and Year-End Earnings Results

    TARRYTOWN, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 fourth quarter and year-end earnings release on Thursday, May 5, 2022 after the market close. The following morning, May 6, at 8:30 a.m. ET, the Company will host a conference call to discuss the results as well as for a discussion into the Company’s leading business attributes. To participate via phone listeners calling from the U.S. and Canada may

  • GlobeNewswire

    Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results

    Revenue of $274.5 Million in Q3, up 14.9% versus Prior Year, up 8.8% on an Organic BasisDiluted EPS of $0.99 in Q3, up 22.2% versus Prior YearNon-GAAP Free Cash Flow of $64.1 Million for Third Quarter Fiscal 2022, up Double-digits versus Prior YearRaising Full-Year Fiscal 2022 Outlook TARRYTOWN, N.Y., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter ended December 31, 2021. “We are pleased with our third quarter